PET-CT在肿瘤放射治疗中的应用

夏伟; 罗全勇; 袁志斌; 夏伟; 罗全勇; 袁志斌

[1]

Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality. Int J Radiat Oncol Biol Phys, 2000, 47(3):551-560.

[2]

MacManus MP, Hicks BJ, Ball DL, et aL F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma:powerful correlation with survival and high impact on treatment. Cancer, 2001, 92(4):886-895.

[3]

Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of (18)F-fluoro-2-dexoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Racliother Oncol,2000, 55(3):317-324.

[4]

Bradley JD, Perez CA, Dehdashti F, et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med, 2004, 45(suppl 1):S96-S101.

[5]

Erdi YE, Bosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol, 2002, 62(1):51-60.

[6]

Schmidt S, Nestle U, Walter K, et al. Optimization of radioth-erapy planning for non-small cell lung cancer(NSCLC) using ¹⁸FDG-PET.Nuklearmedizin, 2002, 41(5):217-220.

[7]

Schmucking M, Baum RP, Griesinger F, et al. Molecular wholebodycancer staging using positron emission tomography:consequences for therapeutic management and metabolic radiation treatment planning Recent Results Cancer Res, 2003, 162(1):195-202.

[8]

刘俐,孙世良.适形调强放射治疗技术.中国肿瘤,2004,13(3):194-196.

[9]

Akhuret T, Downey RJ, Ginsberg MS, et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg, 2002, 73(1):259-264.

[10]

Magnani P, Carretta A, Bizzo G, et al. FDG/FET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg, 1999, 40(5):741-748.

[11]

Kieman PD, Sheridan MJ, Lamberti J, et al. Mediastinal staging of non-small cell lung carcinoma using computed computed and positron-emission tomography. South Med J, 2002, 95(10):1168-1172.

[12]

Mah K, Caldwell CB, Ung YC, et al. The impact of ¹⁸FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma:a prospective study. Int J Radiat Oncol Biol Phys, 2002, 52(2):339-350.

[13]

Caldwell CB, Mall K, Ung YC, et al. Observer variation in contouriag gross tumor volume in patients with poorly defined nonsmall-cell lung tumors on CT:the impact of ¹⁸FDG-hybrid PET fusion. Int J Badiat Oncol Biol Phys, 2001, 51(4):923-931.

[14]

余党凡,左传涛,戴嘉中,等.FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究.癌症,2004,23(增1):1538-1541.

[15]

胡永成.全国骨转移瘤治疗专题座谈会会议纪要.中华骨科杂志,2003,23(6):323-325.

[16]

Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease:initial experience with (18)F-fluoride PET/CT and comparison between (18)F-Fluoride PET and (18)F-fluoride PET/CT. J Nucl Meal, 2004, 45(2):272-278.

[17]

朱晓霞,陈永清,陈龙华.PET/CT图像融合对骨转移瘤放射治疗肿瘤区勾画的影响.第一军医大学学报,2004,24(6):700-702.

[18]

张立颖.¹⁸F-FDG PET显像在恶性淋巴瘤中的应用.国外医学·放射医学核医学分册,2001,25(1):10-12.

[19]

Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer.Med Phys, 2002, 29(3):366-371.